Marie Curie

Michele Young named one of USA TODAY's Women of the Year along with other heroines who have made a significant impact in their communities and across the country

Retrieved on: 
Donnerstag, Februar 29, 2024

CINCINNATI, Feb. 29, 2024 /PRNewswire/ -- Today Michele Young, an acclaimed Cincinnati lawyer, mother of five, advanced-stage breast cancer survivor and tireless advocate for social justice was named one of USA Today's Women of the Year.

Key Points: 
  • "Imagine the extraordinary potential that will be unleashed when an epidemic that strikes one in seven women is erased from this earth," said Young.
  • Michele witnessed changes in breast cancer science first-hand as a stage 4 patient in the cancer wards of our nation.
  • She learned of Cleveland Clinic's Dr. Thomas Budd who is studying a vaccine in those with triple-negative breast cancer.
  • Or those women who are killed by the disease – one woman every 14 seconds – taking her from her world," said Young.

Accent Therapeutics Bolsters Leadership Team with Key Executive Hires

Retrieved on: 
Donnerstag, September 21, 2023

LEXINGTON, Mass., Sept. 21, 2023 /PRNewswire/ -- Accent Therapeutics, a biopharmaceutical company pioneering a new class of small molecule precision cancer therapies, today announced the appointments of Jason Sager, M.D., as Chief Medical Officer, Steven Mennen, Ph.D., as Vice President of Pre-Clinical Development and Stuart Ince, Ph.D. as Vice President of Program Leadership.

Key Points: 
  • "Our dedication to fortifying our team underscores the remarkable progress we've achieved as Accent advances its lead programs towards the clinic," said Shakti Narayan, Chief Executive Officer of Accent.
  • Together, Jason, Steven, and Stuart's combined experience will be immensely valuable as Accent moves towards becoming a clinical-stage company and bringing novel therapies to patients."
  • These key executive hires enhance Accent's positioning to potentially advance two investigational programs into the clinic.
  • Accent is also on track to begin IND-enabling studies for a second undisclosed program by the end of 2023.

Curium Acquires Austrian Radiopharmaceuticals Company IASON

Retrieved on: 
Dienstag, Juni 1, 2021

Paris, May 31, 2021 (GLOBE NEWSWIRE) -- (Graz and Paris June 1st, 2021) Curium has successfully completed the acquisition of the Austrian radiopharmaceuticals Company IASON, further expanding its footprint in Europe for its broad portfolio of life saving diagnostic solutions.

Key Points: 
  • Paris, May 31, 2021 (GLOBE NEWSWIRE) -- (Graz and Paris June 1st, 2021) Curium has successfully completed the acquisition of the Austrian radiopharmaceuticals Company IASON, further expanding its footprint in Europe for its broad portfolio of life saving diagnostic solutions.
  • We are looking forward to integrating IASON into our network of 27 PET sites across Europe says Benoit Woessmer, CEO of PET EUROPE at Curium.
  • The name Curium honors the legacy of pioneering radioactive researchers Marie and Pierre Curie, after whom the radioactive element curium was named and emphasizes our focus on nuclear medicine.
  • IASON, founded in 1994, is an independent Austrian company IASON is a leading specialist in Europe for the development, production and distribution of radiopharmaceuticals for positron-emission-tomography (PET).

Eckert & Ziegler’s GalliaPharm® distributed by Curium in France

Retrieved on: 
Dienstag, März 2, 2021

Berlin, Germany and Paris, France, March 01, 2021 (GLOBE NEWSWIRE) -- Eckert & Ziegler Radiopharma GmbH and Curium PET France have decided to reinforce their existing long term partnership by extending their agreement for the distribution of Galliapharm generators in France, Curium being the partner of choice given the national coverage of its PET network in France .

Key Points: 
  • Berlin, Germany and Paris, France, March 01, 2021 (GLOBE NEWSWIRE) -- Eckert & Ziegler Radiopharma GmbH and Curium PET France have decided to reinforce their existing long term partnership by extending their agreement for the distribution of Galliapharm generators in France, Curium being the partner of choice given the national coverage of its PET network in France .
  • Eckert & Ziegler Radiopharma GmbH is a wholly owned subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG and part of Eckert & Zieglers Medical business segment.
  • Curium PET France results from the acquisition of Laboratoires Cyclopharma by the Curium Group.
  • Curium PET France headquartered in Saint-Beauzire, operates twelve PET sites in France located in Nmes, Paris, Sarcelles, Pessac, Rennes, Nancy, Toulouse, Tours, Glisy, Dijon, Janneyrias and Marseille.

World Radiation Litigation Expert Stuart Smith Available for Interview Now About Health Assessment Report on St. Louis Resident Exposure to Radioactive Wastes

Retrieved on: 
Donnerstag, Mai 2, 2019

And finally, after more than a year of legal and scientific battles, the nation's authority on toxicity released a report which confirms exposure by St. Louis residents to these radioactive toxins is increasing risk of terminal illnesses, including lung and bone cancer.

Key Points: 
  • And finally, after more than a year of legal and scientific battles, the nation's authority on toxicity released a report which confirms exposure by St. Louis residents to these radioactive toxins is increasing risk of terminal illnesses, including lung and bone cancer.
  • Some radioactive materials were used to build structures unwittingly inhabited by St. Louis residents.
  • The Mississippi Division of Radiological Health found radiation from radium on the Street property 500 times the natural level.
  • He is the founder of the Stuart H. Smith Law Clinic and Center for Social Justice at Loyola University New Orleans.

Celebrate Women in STEM for Global Diversity Awareness Month

Retrieved on: 
Montag, Oktober 22, 2018

In a survey by Silicon Valley Bank, it was learned that in China, nearly 80% of tech companies have women in C level jobs.

Key Points: 
  • In a survey by Silicon Valley Bank, it was learned that in China, nearly 80% of tech companies have women in C level jobs.
  • She is one of the first Hispanic women to break into the aerospace industry.
  • Marie Curie, Polish physicist and chemist, who pioneered research on radioactivity after pressing forward and sacrificing much to gain an education, gave courage to generations of women.
  • Monica Eaton-Cardone welcomes the chance to discuss opportunities for women in STEM at upcoming industry events.

Governor General congratulates Canadian Donna Strickland on winning the Nobel Prize in Physics

Retrieved on: 
Dienstag, Oktober 2, 2018

OTTAWA, Oct. 2, 2018 /CNW/ -Governor General Julie Payette joins with thousands of Canadians scientists in hailing the exciting award of the Nobel Prize in Physics to Dr. Donna Strickland and her partner Grard Mourou for ground-breaking work in high-intensity ultra-short laser pulses.

Key Points: 
  • OTTAWA, Oct. 2, 2018 /CNW/ -Governor General Julie Payette joins with thousands of Canadians scientists in hailing the exciting award of the Nobel Prize in Physics to Dr. Donna Strickland and her partner Grard Mourou for ground-breaking work in high-intensity ultra-short laser pulses.
  • "I am absolutely thrilled by this news," says Madame Payette.
  • "Dr. Strickland is the first woman to win the prestigious Nobel in Physics in 55 years and only the third woman.
  • She joins legend Marie Curie, Albert Einstein and our Canadian researcher Art McDonald in the esteemed group of laureates.